foxo4-dri senolytic or senomorphic Class II senolytics inhibit survival pathways elicited by senescent FOXO4-DRI Dosing: 1mg Senolytic Protocol
FOXO4 DRI Dosing: 1mg Senolytic Protocol (2026) Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link
Pay in 4 interest-free payments of $5.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



